Skip to main content

Table 3 Recovery of titanium for male and female rats in the summed investigated organs* as percentage of dose administered after single or repeated dosing

From: Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats

  

Day 2/6**

Day 14

Day 30

Day 90

Single

     

NM-100

Male

75 ± 3

nd

nd

55 ± 3

 

Female

72 ± 8

nd

nd

57 ± 1

NM-102

Male

64 ± 4

nd

nd

52 ± 5

 

Female

59 ± 6

nd

nd

53 ± 1

NM-103

Male

86 ± 17

nd

nd

91 ± 12

 

Female

108 ± 8

nd

nd

103 ± 12

NM-104

Male

95 ± 18

nd

nd

109 ± 7

 

Female

89 ± 5

nd

nd

100 ± 4

Repeated

     

NM-100

Male

71 ± 8

69 ± 4

70 ± 4

59 ± 5

 

Female

73 ± 6

nd

nd

61 ± 7

NM-102

Male

66 ± 14

69 ± 6

70 ± 3

54 ± 1

 

Female

65 ± 8

nd

nd

55 ± 1

NM-103

Male

95 ± 6

110 ± 21

96 ± 19

72 ± 13

 

Female

88 ± 7

nd

nd

84 ± 3

NM-104

Male

75 ± 5

99 ± 3

81 ± 10

77 ± 6

 

Female

88 ± 10

nd

nd

86 ± 4

  1. *liver, spleen, kidney, lung, heart, brain, thymus, blood, testes/ovaries.
  2. **Day 2 or day 6 corresponds to single or repeated dosing respectively.
  3. nd: not determined.